Embryomic/LinkedIn
Oct 18, 2025, 09:22
Decoding Mitochondrial Signals in Embryo Selection – Embryomic
Embryomic shared a post on LinkedIn:
“Decoding mitochondrial signals in embryo selection
Today we’re sharing Preprint #5: Metabolomic IVF Embryo Selection Testing, and the Oocyte–Blastocyst Mitochondrial Dichotomy Explained.
This paper details the mitochondrial pathway signatures observed in spent blastocyst media and how they inform the PMT-BC prediction of implantation potential. It’s the biological foundation linking our mass spectral features to meaningful clinical outcomes.
Read the preprint.
If you’re a clinician, embryologist, or researcher working at the intersection of mitochondria, metabolism, and embryo viability, we’d love to compare notes.”
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 21, 2025, 06:53New Guidelines on Frozen Embryo Transfer Released – RBMO
-
Dec 21, 2025, 06:32What is JAMA+ Women’s Health? – JAMA+ Women’s Health
-
Dec 21, 2025, 06:20Contraceptive Use and Ovarian Reserve Interactions – Fertility and Sterility
-
Dec 21, 2025, 02:55Epigenetic Links Between Paternal Age, Reproduction and Offspring Health – Reproduction and Fertility
-
Dec 21, 2025, 02:43Medicines and Pregnancy: ANSM Proposes New Labeling – B’RIGHT
-
Dec 21, 2025, 02:28Steven Palter: It is time to retire the out of date ‘2 week wait’ for pregnancy tests after IVF
-
Dec 21, 2025, 02:24Thorsten Waloschek: New Study Highlights Preeclampsia Risk Stratification Benefits
-
Dec 21, 2025, 02:15Siddhartha Yadav: New ASCO Guideline for Managing Cancer During Pregnancy
-
Dec 21, 2025, 01:56New Patient Resource on Thyroid Issues in Pregnancy – RCOG